References
- Song EM, Yang SK. Natural history of inflammatory bowel disease: a comparison between the East and the West. Intest Res 2022;20:418-430. https://doi.org/10.5217/ir.2021.00104
- Turner D, Ricciuto A, Lewis A, et al.; International Organization for the Study of IBD. STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology 2021;160:1570-1583. https://doi.org/10.1053/j.gastro.2020.12.031
- Seong G, Song JH, Kim JE, et al. Histologic activity and steroid use history are risk factors of clinical relapse in ulcerative colitis with Mayo endoscopic subscore of 0 or 1. Inflamm Bowel Dis 2023;29:238-244. https://doi.org/10.1093/ibd/izac075
- Jangi S, Yoon H, Dulai PS, et al. Predictors and outcomes of histological remission in ulcerative colitis treated to endoscopic healing. Aliment Pharmacol Ther 2020;52:1008-1016. https://doi.org/10.1111/apt.16026
- Shin SY, Kim HS, Kim K, et al. Histologic features and predicting prognosis in ulcerative colitis patients with mild endoscopic activity. Korean J Intern Med 2023 Dec 13 [Epub]. DOI:10.3904/kjim.2023.167.
- Bressenot A, Salleron J, Bastien C, Danese S, Boulagnon-Rombi C, Peyrin-Biroulet L. Comparing histological activity indexes in UC. Gut 2015;64:1412-1418. https://doi.org/10.1136/gutjnl-2014-307477
- Korelitz BI. Mucosal healing as an index of colitis activity: back to histological healing for future indices. Inflamm Bowel Dis 2010;16:1628-1630. https://doi.org/10.1002/ibd.21268
- Peyrin-Biroulet L, Bressenot A, Kampman W. Histologic remission: the ultimate therapeutic goal in ulcerative colitis? Clin Gastroenterol Hepatol 2014;12:929-934.e2. https://doi.org/10.1016/j.cgh.2013.07.022
- Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer. Gastroenterology 2011;140:1807-1816. https://doi.org/10.1053/j.gastro.2011.01.057
- Ahmad HA, East JE, Panaccione R, et al. Artificial intelligence in inflammatory bowel disease: implications for clinical practice and future directions. Intest Res 2023;21:283-294.
- Takenaka K, Kawamoto A, Okamoto R, Watanabe M, Ohtsuka K. Artificial intelligence for endoscopy in inflammatory bowel disease. Intest Res 2022;20:165-170. https://doi.org/10.5217/ir.2021.00079